In this issue of Hematology/Oncology Clinics, guest editor Dr. Harold J. Burstein brings his considerable expertise to Breast Cancer. Top experts provide a comprehensive update on multidisciplinary management of early- and late-stage breast cancer, including key topics such as global perspectives on the epidemiology and treatment of breast cancer; breast cancer pathology in the era of genomics; optimizing radiation therapy after breast conserving surgery; and more.
Contains 16 relevant, practice-oriented topics including disparities in breast cancer outcomes and how to resolve them; genetic testing in breast cancer; the role of ovarian suppression in early stage premenopausal breast cancer; multidisciplinary management of brain metastases from breast cancer; evidence-based guidance for breast cancer survivorship; and more.
Provides in-depth clinical reviews on breast cancer, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Disparities in Breast Cancer Outcomes and How to Resolve Them - p. 1 9. Testing for Inherited Susceptibility to Breast Cancer - p. 17 10. Breast Cancer Pathology in the Era of Genomics - p. 33 11. Surgical Management of the Axilla for Breast Cancer - p. 51 12. Role of Ovarian Suppression in Early Premenopausal Breast Cancer - p. 79 13. Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer - p. 89 14. Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer - p. 103 15. Biology and Treatment of HER2-Low Breast Cancer - p. 117 16. Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer - p. 133 17. Current and Emerging Role of Antibody–Drug Conjugates in HER2-Negative Breast Cancer - p. 151 18. The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer - p. 169 19. Multidisciplinary Management of Brain Metastasis from Breast Cancer - p. 183 20. Systemic Therapy for Hereditary Breast Cancers - p. 203 21. Evidence-Based Guidance for Breast Cancer Survivorship - p. 225
In this issue of Hematology/Oncology Clinics, guest editor Dr. Harold J. Burstein brings his considerable expertise to Breast Cancer. Top experts provide a comprehensive update on multidisciplinary management of early- and late-stage breast cancer, including key topics such as global perspectives on the epidemiology and treatment of breast cancer; breast cancer pathology in the era of genomics; optimizing radiation therapy after breast conserving surgery; and more.
Contains 16 relevant, practice-oriented topics including disparities in breast cancer outcomes and how to resolve them; genetic testing in breast cancer; the role of ovarian suppression in early stage premenopausal breast cancer; multidisciplinary management of brain metastases from breast cancer; evidence-based guidance for breast cancer survivorship; and more.
Provides in-depth clinical reviews on breast cancer, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Disparities in Breast Cancer Outcomes and How to Resolve Them - p. 1 9. Testing for Inherited Susceptibility to Breast Cancer - p. 17 10. Breast Cancer Pathology in the Era of Genomics - p. 33 11. Surgical Management of the Axilla for Breast Cancer - p. 51 12. Role of Ovarian Suppression in Early Premenopausal Breast Cancer - p. 79 13. Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer - p. 89 14. Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer - p. 103 15. Biology and Treatment of HER2-Low Breast Cancer - p. 117 16. Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer - p. 133 17. Current and Emerging Role of Antibody–Drug Conjugates in HER2-Negative Breast Cancer - p. 151 18. The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer - p. 169 19. Multidisciplinary Management of Brain Metastasis from Breast Cancer - p. 183 20. Systemic Therapy for Hereditary Breast Cancers - p. 203 21. Evidence-Based Guidance for Breast Cancer Survivorship - p. 225
